SCHEDULE 13G/A

QUINCE THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 22053A107

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Sofinnova Capital VIII

  Shares: 1,197,711.00 · Class: 2.7%

• Sofinnova Partners SAS, a French Corporation

  Shares: 1,197,711.00 · Class: 2.7%

• Antoine Papiernik

  Shares: 1,197,711.00 · Class: 2.7%

• Henrijette Richter

  Shares: 1,197,711.00 · Class: 2.7%

• Maina Bhaman

  Shares: 1,197,711.00 · Class: 2.7%

• Graziano Seghezzi

  Shares: 1,197,711.00 · Class: 2.7%

• Anta Gkelou

  Shares: 1,197,711.00 · Class: 2.7%

• Karl Naegler

  Shares: 1,197,711.00 · Class: 2.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.